Literature DB >> 3283193

The medical prevention of variceal bleeding.

D Lebrec1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3283193     DOI: 10.1007/bf00257458

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  25 in total

1.  Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension.

Authors:  A Gatta; D Sacerdoti; C Merkel; L Milani; G Battaglia; R Zuin
Journal:  Am Heart J       Date:  1984-10       Impact factor: 4.749

2.  Treatment of acute variceal bleeding.

Authors:  J Bernuau; B Rueff
Journal:  Clin Gastroenterol       Date:  1985-01

3.  Acute and chronic effects of the beta-receptor blocker mepindolol on hemodynamics and the portal circulation.

Authors:  K Wink
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1984-08

4.  Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis.

Authors:  P Hillon; D Lebrec; C Muńoz; M Jungers; G Goldfarb; J P Benhamou
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

5.  The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.

Authors:  D Lebrec; P Hillon; C Muńoz; G Goldfarb; O Nouel; J P Benhamou
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

6.  Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis.

Authors:  A K Burroughs; W J Jenkins; S Sherlock; A Dunk; R P Walt; T O Osuafor; S Mackie; R Dick
Journal:  N Engl J Med       Date:  1983-12-22       Impact factor: 91.245

7.  Metoprolol in portal hypertension. A controlled study.

Authors:  G H Bützow; J Remmecke; A Bräuer
Journal:  Klin Wochenschr       Date:  1982-10-15

8.  Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis.

Authors:  J Bosch; R Masti; D Kravetz; J Bruix; J Gaya; J Rigau; J Rodes
Journal:  Hepatology       Date:  1984 Nov-Dec       Impact factor: 17.425

9.  Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model.

Authors:  R J Kroeger; R J Groszmann
Journal:  Hepatology       Date:  1985 Jan-Feb       Impact factor: 17.425

10.  Propranolol--a medical treatment for portal hypertension?

Authors:  D Lebrec; O Nouel; M Corbic; J P Benhamou
Journal:  Lancet       Date:  1980-07-26       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.